A Delphi Process for Reaching Nationwide Consensus on Antimicrobial Intravenous-to-oral Switch Criteria and Development of an Antimicrobial Intravenous-to-oral Switch Decision Aid

Eleanor J Harvey, Kieran Hand, Dale Weston, Diane Ashiru-Oredope
doi: https://doi.org/10.1101/2022.11.12.22282255

Article Information

doi 
https://doi.org/10.1101/2022.11.12.22282255
History 
  • November 14, 2022.
Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.

Author Information

  1. Eleanor J Harvey1,
  2. Kieran Hand2,
  3. Dale Weston3 and
  4. Diane Ashiru-Oredope1,*
  1. 1Healthcare-Associated Infection (HCAI), Fungal, Antimicrobial Resistance (AMR), Antimicrobial Use (AMU) & Sepsis Division, United Kingdom Health Security Agency (UKHSA), London, UK
  2. 2Antimicrobial Resistance Programme, NHS England, London, UK
  3. 3Behavioural Science and Insights Unit, UKHSA, Porton Down, Salisbury, UK
  1. ↵*Corresponding Author Diane Ashiru-Oredope: diane.ashiru-oredope{at}ukhsa.gov.uk, +44 2083 276689
Back to top
Posted November 14, 2022.
Download PDF

Supplementary Material

Data/Code
Email
A Delphi Process for Reaching Nationwide Consensus on Antimicrobial Intravenous-to-oral Switch Criteria and Development of an Antimicrobial Intravenous-to-oral Switch Decision Aid
Eleanor J Harvey, Kieran Hand, Dale Weston, Diane Ashiru-Oredope
medRxiv 2022.11.12.22282255; doi: https://doi.org/10.1101/2022.11.12.22282255
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area